Back to Search
Start Over
A Phase II Open-Label, Single-arm Clinical Trial to Study the Safety, Efficacy and Pharmacokinetics of MK-3009 (Daptomycin) in Japanese Pediatric Participants Aged 1 to 17 Years With cSSTI or Bacteremia Caused by Gram-positive Cocci
A Phase II Open-Label, Single-arm Clinical Trial to Study the Safety, Efficacy and Pharmacokinetics of MK-3009 (Daptomycin) in Japanese Pediatric Participants Aged 1 to 17 Years With cSSTI or Bacteremia Caused by Gram-positive Cocci
- Source :
- Pharma Business Week. September 10, 2018, 141
- Publication Year :
- 2018
-
Abstract
- 2018 SEP 10 (NewsRx) -- By a News Reporter-Staff News Editor at Pharma Business Week -- Staff editors report on the newly launched clinical trial, NCT03643952, which has the following [...]
Details
- Language :
- English
- ISSN :
- 15436675
- Database :
- Gale General OneFile
- Journal :
- Pharma Business Week
- Publication Type :
- News
- Accession number :
- edsgcl.553547434